Skip to main content
. 2016 Apr 28;7(21):31079–31087. doi: 10.18632/oncotarget.9075

Figure 1. Disease-free survival and overall survival by Ki-67 expression level.

Figure 1

(A) The 3-year DFS was significantly better in low Ki-67 group than in the high Ki-67 group (90.8% vs 78.4% Log-rank p = 0.001) and (B) A poorer 3-year OS was also detected in high Ki-67 group (98.0% vs 90.4% Log-rank p = 0.000).